SUVENPHAR2023-07-012023-09-30 SUVENPHAR2023-07-012023-09-30 SUVENPHAR2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member SUVENPHAR2023-07-012023-09-30in-bse-fin:OneOperatingExpenses02Member SUVENPHAR2023-07-012023-09-30in-bse-fin:OneOperatingExpenses03Member SUVENPHAR2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member SUVENPHAR2023-07-012023-09-30in-bse-fin:FourOperatingExpenses02Member SUVENPHAR2023-07-012023-09-30in-bse-fin:FourOperatingExpenses03Member SUVENPHAR2023-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543064 SUVENPHAR NOTLISTED Suven Pharmaceuticals Limited Equity 2023-04-01 2024-03-31 2023-11-09 2023-11-02 INR Lakhs Half yearly 16:00:00 17:25:00 2023-11-09 2023-11-09 true Cash Flow Indirect Not applicable Single segment Contract Development and Manufacturing 2023-07-01 2023-09-30 Unaudited Consolidated 2310537000.00 198417000.00 2508954000.00 511560000.00 0.00 64473000.00 285768000.00 5028000.00 118919000.00 469123000.00 1454871000.00 1054083000.00 0.00 1054083000.00 242926000.00 15516000.00 258442000.00 0.00 795641000.00 0.00 0.00 0.00 0.00 795641000.00 0.00 795641000.00 0.00 0.00 254565000.00 1 3.13 3.13 0.00 0.00 3.13 3.13 Notes: 1) The above financial results of the Company have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 9th November, 2023.The results for the for the quarter ended 30th September , 2023 has been reviewed by our statutory auditors. 2) The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder. 3) The consolidated financial results include the results of the wholly owned subsidiarIes Suven Pharma, Inc.,USA & Casper Pharma Pvt Ltd. 4) The Company reportable activity falls under single business segment and hence, segment reporting as per IND AS 108 (Operating Segment) is not presented. 5) As per share purchase agreement dated 26th December, 2022 entered into by and between Berhyanda Limited (Buyer), Jasti Property and Equity Holdings Private Limited (in their capacity as sole trustee of Jasti Family Trust) (Seller) and Venkateswarlu Jasti (seller representative) pursuant to SEBI SAST Regulations, 2011 as amended, M/s Berhyanda Limited, a Cyprus based company and an investment arm of Advent International Corporation, USA has acquired controlling stake to the tune of 12,75,37,043 equity shares aggregating to 50.10 % in the Company on 29th September, 2023 from the Seller. 6) The corresponding previous period figures have been regrouped/reclassified where ever necessary. Single segment 2023-04-01 2023-09-30 Unaudited Consolidated 5786038000.00 305068000.00 6091106000.00 1309278000.00 0.00 279471000.00 573208000.00 16493000.00 244331000.00 974811000.00 3397592000.00 2693514000.00 0.00 2693514000.00 656033000.00 35941000.00 691974000.00 0.00 2001540000.00 0.00 0.00 0.00 0.00 2001540000.00 91000.00 2001631000.00 0.00 0.00 254565000.00 1 7.86 7.86 0.00 0.00 7.86 7.86 Manufacturing Expenses 292786000.00 Other Expenses 131598000.00 R & D expenses 44739000.00 Manufacturing Expenses 615539000.00 Other Expenses 293653000.00 R & D expenses 65619000.00 5716711000.00 1723271000.00 0.00 792684000.00 1170966000.00 272000.00 68183000.00 1239421000.00 34960000.00 9507047000.00 2714629000.00 6528758000.00 1368987000.00 575767000.00 32292000.00 2657000.00 1550000.00 8510011000.00 466047000.00 11690687000.00 21197734000.00 254565000.00 19099473000.00 19354038000.00 19354038000.00 0.00 8678000.00 8678000.00 92172000.00 619061000.00 719911000.00 491331000.00 425939000.00 102481000.00 1019751000.00 49081000.00 50968000.00 3985000.00 1123785000.00 1843696000.00 21197734000.00 16493000.00 413476000.00 -262827000.00 0.00 532677000.00 -4755000.00 0.00 0.00 0.00 -225721000.00 0.00 19554000.00 0.00 241038000.00 0.00 11507000.00 9222000.00 -37067000.00 0.00 6865000.00 0.00 63539000.00 0.00 0.00 0.00 259000.00 0.00 0.00 0.00 657182000.00 3350696000.00 0.00 0.00 0.00 654801000.00 -172833000.00 2523062000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 268184000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2174060000.00 0.00 0.00 0.00 0.00 0.00 0.00 71024000.00 0.00 -7680000.00 0.00 -2378900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -204678000.00 0.00 0.00 -4749000.00 0.00 16493000.00 0.00 0.00 -216422000.00 -72260000.00 0.00 -72260000.00 648027000.00 575767000.00 0.00 121000.00 0.00 30000.00 0.00 0.00